News for '-drug-price-control-order'

Delhi HC sets aside government decision to cap condom prices

Delhi HC sets aside government decision to cap condom prices

Rediff.com11 Jul 2015

In a relief to pharma majors, the Delhi high court today held as "illegal and unsustainable" the Centre's decision to put a ceiling on the price of condoms, including the luxury variety.

'What we do is determined by national interest'

'What we do is determined by national interest'

Rediff.com24 May 2017

If people can lobby me for making changes in policies that goes against the country's interest, I won't keep myself in this position, says the vice chairman of NITI Aayog.

Bulk drug prices may rise this fiscal

Bulk drug prices may rise this fiscal

Rediff.com15 Apr 2014

The industry feels that prices of active pharmaceutical ingredients (APIs) can go up in the range of 5-15 per cent.

Regulatory pain for GSK's Crocin Advance

Regulatory pain for GSK's Crocin Advance

Rediff.com28 Mar 2014

The NPPA letter was issued to GSK on Wednesday.

Prices of key drugs to be cut by up to half

Prices of key drugs to be cut by up to half

Rediff.com17 Jun 2013

The National Pharmaceutical Pricing Authority will soon notify prices of as many as 150 packs of essential medicines in line with the new pharma pricing policy, according to official sources.

Pharma sector in alarm over govt's cure

Pharma sector in alarm over govt's cure

Rediff.com28 Oct 2017

The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.

Why price cap on drugs is counter productive

Why price cap on drugs is counter productive

Rediff.com31 May 2016

To ensure equal access to health care, the government must consider it in a holistic manner and improve all parameters.

Pharma in 2014: Deals worth billions and fines worth millions

Pharma in 2014: Deals worth billions and fines worth millions

Rediff.com26 Dec 2014

In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.

« Prev  |